It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
"There is no clinical evidence that current smoking is a predisposing factor for hospitalisation for Covid-19. On the contrary, the data I and other experts have studied, suggests that current smokers are significantly less likely to be hospitalised".
"The Chinese are amongst the biggest smokers in the world, with more than half of all adult men indulging in the habit.
As a cardiologist with a career devoted to tobacco harm reduction, I obviously closely monitor health developments in the country that consumes approximately one third of the planet’s cigarettes.
So, when Covid-19 was already on its relentless march around the globe earlier this year, I was struck by one apparently paradoxical statistic that kept standing out in the blizzard of new data emerging from China, ground zero of the disease.
In a country where 26.6% of all adults smoke (approximately 50% among men), very few of those hospitalised seemed to be smokers....."
First peer reviewed study to show Nicotine offers potential protection against Covid 19
Disclaimer: News24 encourages freedom of speech and the expression of diverse views. The views of columnists published on News24 are therefore their own and do not necessarily represent the views of News24.
Internal and Emergency Medicine is an independent, international journal devoted to all topics related to science and practice of internal and emergency medicine and designed for internists and emergency physicians. The Journal publishes Original articles, Review articles, Letters to the Editor, Editorials and Commentaries and it encourages letters of rebuttal and criticism of published articles.
Sort of different from the claim of the OP.
This preliminary analysis, assuming that the reported data are accurate, suggests that current smoking does not appear to be a predisposing factor for hospitalization for COVID-19.
THC has been shown to act as an antiinflammatory agent, so it seemed likely to the team that it could have a role in stopping inflammation in the lungs. They found that in 100 percent of cases, THC protected the mice against lethal symptoms that happen after a cytokine storm by blocking the pro-inflammatory cytokines that bring immune cells to the area and cause damage. Not only this, THC actually increased the anti-inflammatory activity, slowing the inflammation and stopping the severe damage caused.